\-\ Texto\\:\\ \ \(0\)\
\-\ high\\ dose\\ steroid\\ therapy\\.\ \(0\)\
\-\ amorphous\\ soft\\ tissue\\ swelling\\ in\\ the\\ periorbital\\ soft\\ tissues\\ on\\ the\\ left\\,\\ pronounced\\ asymmetric\\ swelling\\ of\\ the\\ extraocular\\ muscles\\ \\(extending\\ to\\ the\\ tendinous\\ insertions\\)\\ and\\ inflammatory\\ changes\\ of\\ the\\ intraconal\\ fat\\.\ \(0\)\
\-\ orbital\\ pseudotumor\ \(6\)\
\-\ thyroid\\ eye\\ disease\ \(0\)\
\-\ orbital\\ myositis\ \(1\)\
\-\ sjogren\\'s\\ disease\ \(0\)\
\-\ orbital\\ pseudotumor\ \(6\)\
\-\ infections\\ orbital\\ cellulitis\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ 30\\ yo\\ woman\\ with\\ acute\\ onset\\ of\\ eye\\ pain\\ and\\ left\\ eye\\ swelling\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ orbital\\:\\ 0\\.47197781726926735\ \(0\)\
\-\ eye\\:\\ 0\\.32284820641029227\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.2793978164784248\ \(0\)\
\-\ swelling\\:\\ 0\\.2716216090534023\ \(0\)\
\-\ insertions\\:\\ 0\\.17966165390228825\ \(0\)\
\-\ sjogren\\:\\ 0\\.17966165390228825\ \(0\)\
\-\ tendinous\\:\\ 0\\.1749293440855718\ \(0\)\
\-\ intraconal\\:\\ 0\\.1709897968439906\ \(0\)\
\-\ amorphous\\:\\ 0\\.16204049581127022\ \(0\)\
\-\ periorbital\\:\\ 0\\.15653128156834895\ \(0\)\
\-\ pronounced\\:\\ 0\\.1504957415206827\ \(0\)\
\-\ myositis\\:\\ 0\\.1497470289278647\ \(0\)\
\-\ extraocular\\:\\ 0\\.1463232791430969\ \(0\)\
\-\ soft\\:\\ 0\\.1432343284951336\ \(0\)\
\-\ cellulitis\\:\\ 0\\.14118882252721732\ \(0\)\
\-\ the\\:\\ 0\\.13421103014464023\ \(0\)\
\-\ steroid\\:\\ 0\\.12966061153146433\ \(0\)\
\-\ dose\\:\\ 0\\.12562451362965488\ \(0\)\
\-\ asymmetric\\:\\ 0\\.12106142776895228\ \(0\)\
\-\ infections\\:\\ 0\\.11877411097154827\ \(0\)\
\-\ muscles\\:\\ 0\\.11528083578079144\ \(0\)\
\-\ disease\\:\\ 0\\.11293592397282369\ \(0\)\
\-\ tissues\\:\\ 0\\.10606324441617607\ \(0\)\
\-\ thyroid\\:\\ 0\\.10571896872782065\ \(0\)\
\-\ left\\:\\ 0\\.09177743501334898\ \(0\)\
\-\ 30\\:\\ 0\\.09176906754648877\ \(0\)\
\-\ extending\\:\\ 0\\.09120829556944846\ \(0\)\
\-\ inflammatory\\:\\ 0\\.09096328073355121\ \(0\)\
\-\ onset\\:\\ 0\\.0863810189256063\ \(0\)\
\-\ yo\\:\\ 0\\.08404231776342459\ \(0\)\
\-\ fat\\:\\ 0\\.08368158467505477\ \(0\)\
\-\ changes\\:\\ 0\\.0813000707406922\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0801167556761863\ \(0\)\
\-\ of\\:\\ 0\\.07897664681267928\ \(0\)\
\-\ therapy\\:\\ 0\\.07729216847786348\ \(0\)\
\-\ high\\:\\ 0\\.07645403954930094\ \(0\)\
\-\ acute\\:\\ 0\\.0727717812814051\ \(0\)\
\-\ tissue\\:\\ 0\\.07056771563784749\ \(0\)\
\-\ woman\\:\\ 0\\.07006000031575527\ \(0\)\
\-\ and\\:\\ 0\\.055595047758089676\ \(0\)\
\-\ pain\\:\\ 0\\.04813726770731882\ \(0\)\
\-\ on\\:\\ 0\\.040628244655707996\ \(0\)\
\-\ to\\:\\ 0\\.033630477152138134\ \(0\)\
\-\ in\\:\\ 0\\.03346494801324642\ \(0\)\
\-\ with\\:\\ 0\\.02634127844677692\ \(0\)\
